What was Cencora's (formerly AmerisourceBergen) top-line performance in the first quarter of fiscal year 2008?

Cencora reported total revenue of $17.8 billion for the quarter ended March 31, 2008, an increase of 8% compared to the same period last year. This growth was primarily attributed to its Pharmaceutical Distribution segment and the recent acquisition of Bellco Health.

How did the company's profitability fare during the quarter?

While revenue grew, gross profit decreased by 8% to $558.8 million. This was largely influenced by the divestiture of the Long-Term Care business in the prior year. However, operating income saw a healthy increase of 7% to $236.7 million, indicating improved operational efficiency within the core business.

What is the status of Cencora's share repurchase program?

The company actively continued its share repurchase program, purchasing $395.2 million of its common stock in the first six months of fiscal 2008. As of March 31, 2008, approximately $302.4 million in repurchase authorization remained.

Did the company make any significant acquisitions during this period?

Yes, Cencora acquired Bellco Health for $162.2 million on October 1, 2007. Bellco is a pharmaceutical distributor in the Metro New York City area, and its acquisition expands Cencora's presence in that market.

COR 10-Q Quarterly Report Q2 FY2008 — Revenue, Net Income, EPS

Summary

Cencora, Inc. (COR), formerly AmerisourceBergen Corporation, reported its first quarter fiscal year 2008 results, ending March 31, 2008. The company demonstrated revenue growth, primarily driven by its Pharmaceutical Distribution segment, with an 8% increase in total revenue to $17.8 billion for the quarter. This growth was supported by the acquisition of Bellco Health and organic growth within the AmerisourceBergen Drug Corporation (ABDC) operations. Despite revenue increases, gross profit saw a decrease of 8% to $558.8 million, largely influenced by the divestiture of the Long-Term Care business. Operating income, however, rose by 7% to $236.7 million, highlighting operational efficiencies and segment performance. The company's balance sheet shows total assets of $12.6 billion, with significant goodwill reflecting past acquisitions. Liabilities are dominated by accounts payable, totaling $7.4 billion. Stockholders' equity stood at $2.9 billion. Cash flow from operations for the six months ended March 31, 2008, was $92.3 million, a notable decrease from the prior year, impacted by increased inventory and accounts receivable. The company continued its share repurchase program, buying back approximately $395.2 million in stock during the six-month period, signaling confidence in its financial position and commitment to returning value to shareholders.

Key Highlights

1Total revenue for the quarter ended March 31, 2008, increased by 8% year-over-year to $17.8 billion, driven by the Pharmaceutical Distribution segment.
2Gross profit decreased by 8% to $558.8 million, primarily due to the prior year's inclusion of the divested Long-Term Care business.
3Operating income increased by 7% to $236.7 million, reflecting improved operational performance.
4The company acquired Bellco Health for $162.2 million during the period, expanding its market presence.
5Net income for the quarter rose slightly by 3% to $133.9 million, while diluted earnings per share saw a significant increase of 21% to $0.82, benefiting from share repurchases.
6Cash flow from operations for the six months ended March 31, 2008, was $92.3 million, down from $710.8 million in the prior year, impacted by changes in working capital.
7The company continued its share repurchase program, acquiring $395.2 million of its stock in the first six months of the fiscal year.

Cencora, Inc. Quarterly Report for Q2 Ended Mar 31, 2008

Summary

Key Highlights

Frequently Asked Questions